BioNTech SE ADR (NASDAQ: BNTX) is -15.55% lower on its value in year-to-date trading and has touched a low of $76.53 and a high of $131.49 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The BNTX stock was last observed hovering at around $99.27 in the last trading session, with the day’s loss setting it -3.04%.
Currently trading at $96.23, the stock is -9.88% and -15.53% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.95 million and changing -3.06% at the moment leaves the stock -8.28% off its SMA200. BNTX registered 3.48% gain for a year compared to 6-month loss of -22.84%. The firm has a 50-day simple moving average (SMA 50) of $113.9179 and a 200-day simple moving average (SMA200) of $104.917625.
The stock witnessed a -19.53% gain in the last 1 month and extending the period to 3 months gives it a -15.75%, and is -1.27% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 2.80% over the week and 4.20% over the month.
BioNTech SE ADR (BNTX) has around 6772 employees, a market worth around $23.09B and $2.98B in sales. Profit margin for the company is -24.07%. Distance from 52-week low is 25.74% and -26.82% from its 52-week high. The company has generated returns on investments over the last 12 months (-3.53%).
with sales reaching $167.45M over the same period.The EPS is expected to shrink by -74.06% this year, but quarterly earnings will post -22.07% year-over-year. Quarterly sales are estimated to shrink -10.74% in year-over-year returns.
501.0 institutions hold shares in BioNTech SE ADR (BNTX), with institutional investors hold 59.84% of the company’s shares. The shares outstanding are 239.97M, and float is at 236.22M with Short Float at 1.19%. Institutions hold 22.00% of the Float.
The top institutional shareholder in the company is BAILLIE GIFFORD & CO with over 8.28 million shares valued at $665.08 million. The investor’s holdings represent 3.4425 of the BNTX Shares outstanding. As of 2024-06-30, the second largest holder is PRIMECAP MANAGEMENT CO/CA/ with 4.79 million shares valued at $384.89 million to account for 1.9922 of the shares outstanding. The other top investors are FLOSSBACH VON STORCH AG which holds 4.38 million shares representing 1.8216 and valued at over $351.94 million, while HARDING LOEVNER LP holds 1.2174 of the shares totaling 2.93 million with a market value of $235.22 million.
BioNTech SE ADR (BNTX) Insider Activity
Still, SEC filings show that on Feb 20 ’25, Poetting Sierk (Officer) Proposed Sale 120,000 shares at an average price of $119.58 for $14.35 million. The insider now directly holds shares of BioNTech SE ADR (BNTX).
